1. All Products
  2. DORA - Oral drugs
  3. DELAMANID, 25mg, disp. tab., blister
Public Pricelist

DELAMANID, 25mg, disp. tab., blister

https://medicalguidelines.msf.org/en/node/1651
https://unicat.msf.org/cat/product/86583
STD DORADELA2TD1

Valid Article

Article is intended to be used with children (<12 years) ONLY.
6.2.5 - Antituberculosis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J04AK06
Anatomical Therapeutic Chemical Classification according to WHOCC
P
The order of this product needs to be justified and is only acceptable under certain conditions.
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

DELAMANID

Therapeutic Action

Nitroimidazole antibactericidal

Indications

Drug-Resistant Tuberculosis (DR-TB), in combination with other TB medicines

Some restricted information has been hidden. Sign in to see this information

Instructions for use

The 25 mg dispersible tablet is intended for paediatric use, to be dispersed in water or fruit juice.

Tablets should be swallowed whole if possible.

To be taken with food.

Blister packaging is the packaging of choice for antituberculosis medicines due to the unstable nature of some of them when exposed to higher temperatures and humidity.

The quantity to be ordered is calculated per tablet, not per blister.

Precautions for Use

May cause QT prolongation.

Storage

Below 25ºC - Protect from humidity